Study shows contract treatment outperforms incarceration for substance misuse offenders

FHS
May 6, 2024
6:35 pm

Substance use disorder treatment in the community is a superior alternative to incarceration for offenders with a substance misuse background, according to a recent study evaluating the effectiveness of the contract treatment sanction in Sweden.

Merck winds down Phase 3 TIGIT/PD-1 combo study due to safety-related dropouts

A large number of patient dropouts caused by immune side effects have forced Merck to end a late-stage trial of its anti-TIGIT drug vibostolimab in

May 14, 2024

Advances in targeting the CD47/SIRPα “do not eat me” pathway for cancer therapy

A new editorial was recently published in Oncotarget’s Volume 15, on July 10, 2024, entitled, “The advances in targeting CD47/SIRPα “do not eat me” axis

September 13, 2024

AMR Multi-Stakeholder Partnership Platform develops key recommendations for action on antimicrobial resistance

Antimicrobial resistance (AMR) is one of the top global public health and development threats. According to the World Health Organisation (WHO), an estimated 4.95 million

May 17, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.